Abstract:To die or not to die—that is the question. Up to date, there is accumulating evidence that in addition to necrosis, the programmed cell death plays a significant role in acute or delayed neuronal death in the central nervous system (CNS) disorders, such as neurodegenerative diseases and ischemic stroke. After focusing on necrosis and apoptosis as the major causes of neuronal death in the CNS disorders for dozens of years, it has been recognized that elaborating the mechanisms underlying neuronal death is not as easy as it looks. In recent years, autophagy has become one of the most attractive topics in the research of neuronal death of CNS disorders. The term autophagy comes from the Greek roots “auto” (self) and “phagy” (eating) and means selfdigestion. Previously, autophagy has been viewed as type II programmed cell death with a random process because it appears to engulf cytosol indiscriminately; however, it is now recognized as a tightly regulated endogenous biological response to degrade damaged and dysfunctional cellular organelles and protein aggregates. In neuronal cells, approximately 1% of cellular proteins are catabolized per hour by autophagy, even under nutrient-rich condition. Although it is not fully understood how much the basal autophagy contributes to macromolecule synthesis and energy production in the steady state by supplying amino acids, glucose, and free fatty acids, the role of basal autophagy acting as the quality-control machinery for cytoplasmic components is widely accepted [1]. Many neurodegenerative disorders, such as Parkinson disease (PD) and Alzheimer’s disease (AD), result from proteins that increase their propensity to form aggregates. While autophagy can eliminate aggregated proteins, defective mitochondria, and excessive reactive oxygen species (ROS) that could induce DNA damage and cell death, inadequate or defective autophagy promotes neuronal cell death in most of neurodegenerative disorders. It is becoming increasingly evident that the cell response may shift gradually from elimination of damaged proteins/organelles by autophagy, which leads to its recovery, to the induction of apoptotic or necrotic pathways determining cellular demise under both neurodegenerative disorders and brain ischemia (Figure 1). p62, a hot topic in cell death research in recent years, is a scaffolding protein that binds to polyubiquitin and associated with the nuclear envelope. Previous works reveal that p62 acts as a signaling hub through its ability to recruit and oligomerize important signaling molecules in cytosolic speckles to control cell apoptosis [2]. Thus, p62 is thought to be a detrimental player in the cell life [2]. However, this opinion is being challenged. Recently, p62 was found to be localized to autophagic compartments via preferential binding with LC3-II form, which may assist in removal of cellular proteins damaged by dopaminergic neurotoxin [3] and is involved in the decrease of the neuronal cell number under hypoxic stress [4]. p62 was also reported to be a potential diagnostic tool for Alzheimer’s disease [5]. Further, p62 is recruited to mitochondrial clusters and is essential for the clearance of mitochondria in the pathogenesis of Parkinson’s disease [6–9], although there are minor disputes regarding the detailed mechanisms underlying the effect of p62 on the dysfunctional mitochondrial clustering and mitophagy [6–9]. Thus, whether p62 is a detrimental or a beneficial factor for the survival of neuronal cell depends on the pathological insults and the tissue microenvironment and the switch between autophagy and apoptosis, which is regulated by p62. Autophagy also participates in the cerebral ischemia-induced injury. Accumulating data supported the critical role of autophagy in cerebral ischemia as well as in neurodegenerative diseases [10 –12]. Nevertheless, autophagy may be a double-edged sword for cerebral ischemia [10–12]. We recently reviewed the beneficial and harmful effects of autophagy in cerebral ischemia [13]. In this issue of CNS Neuroscience & Therapeutics, Qi et al. describe a new role for Akt/glycogen synthase kinase 3b (GSK-3b)-dependent

Integrated Proteomics Reveals Autophagy Landscape and an Autophagy Receptor Controlling PKA-RI Complex Homeostasis in Neurons

Integrated Proteomics Reveals the Landscape of Autophagy Degradation in Human Neurons and Autophagy Receptors Regulating Neuronal Activity

Autophagosomes coordinate an AKAP11-dependent regulatory checkpoint that shapes neuronal PKA signaling

Chronic Neuronal Inactivity Utilizes the mTOR-TFEB Pathway to Drive Transcription-Dependent Autophagy for Homeostatic Up-Scaling

Phosphoproteome-based kinase activity profiling reveals the critical role of MAP2K2 and PLK1 in neuronal autophagy

Regulation of neuronal autophagy and the implications in neurodegenerative diseases

Autophagy and Its Comprehensive Impact on ALS

Neuronal Autophagy: Characteristic Features and Roles in Neuronal Pathophysiology

The Multiple Roles of Autophagy in Neural Function and Diseases

The autophagy proteome in the brain

[Autophagy and Neuronal Diseases].

Neuronal Autophagy: Regulations and Implications in Health and Disease

Mechanism and Regulation of Autophagy and Its Role in Neuronal Diseases

Proteasomal inhibition preferentially stimulates lysosome activity relative to autophagic flux in primary astrocytes

Targeted proteomics addresses selectivity and complexity of protein degradation by autophagy

Compromised autophagy and neurodegenerative diseases

AMPK activation does not enhance autophagy in neurons in contrast to MTORC1 inhibition: different impact on β-amyloid clearance

Discovery of a Small-Molecule Modulator of the Autophagy-Lysosome Pathway That Targets Lamin A/C and LAMP1, Induces Autophagic Flux, and Affects Lysosome Positioning in Neurons

A chemical genomics-aggrephagy integrated method studying functional analysis of autophagy inducers

Autophagy in the Disorders of Central Nervous System: Vital And/or Fatal?

Autophagy is a novel pathway for neurofilament protein degradation in vivo